H.C. Wainwright raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $405 from $400 and keeps a Buy rating on the shares ...

But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. So, the natural question for Madrigal Pharmaceuticals (NASDAQ:MDGL) shareholders is whether ...

Over the last 7 days, the United States market has experienced a 3.6% drop, yet it remains up by 17% over the past year with earnings forecasted to grow by 14% annually. In this context of fluctuating ...